We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

News   Mar 12, 2018 | Original Story by Tim Stephens for the university of California Santa Cruz.

 
Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

Immune system antibodies can block RSV infection and provide protection from RSV disease. This image shows how a protective human antibody (dark and light grey surface) sticks to a folded part of the RSV G protein antigen (rainbow colored blue-to-red). The new findings provide a foundation for the development of a RSV vaccine. Credit: Rebecca DuBois.

 
 
 

RELATED ARTICLES

Immune System Protein Helps Suppress HIV

News

A new study reveals the role of a protein that serves to block HIV gene expression once it has entered human cells.

READ MORE

Probiotic Consumption Impacts Breast Milk Composition

News

The complex sugars found in human breastmilk, long believed to be fixed in their composition, may change in women who are taking probiotics.

READ MORE

Can We Restore Memory Function in Alzheimer’s Disease?

News

Research reveals a new approach to Alzheimer's disease (AD) that may eventually make it possible to reverse memory loss, a hallmark of the disease in its late stages.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE